US$ 24.60
glp 1 gip receptor agonist GLP-1 and receptors signal through distinct β-arrestin 2-dependent pathways to regulate pancreatic β cell function New strategies for the treatment
Description
While previous research primarily focused on T2D or obesity-specific populations, our study specifically examines therapeutic implications for MASLD patients, addressing a critical knowledge gap regarding the benefits of combination therapy on various clinical endpoints including all-cause hospitalization, all-cause mortality, MAKE, and MALO in this population

doi: 10.1016/s0006-291x(05)80836-8

having 94% sequence similarity

doi: 10.1016/j.amjmed.2009.11.019

B., Calanna S., Holst J
Lancet 381 , 117124 (2013)
